Behandeling van hypertensie bij vrouwen en mannen

Translated title of the contribution: Sex differences in the pharmacological treatment of hypertension in primary care

Elisa Dal Canto*, Sophie L Theunisse, Michiel L Bots, Frans H Rutten, Marion C J Biermans, N Charlotte Onland-Moret, Wilko Spiering, Birsen Kiliç, Hester M den Ruijter, Monika Hollander

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

OBJECTIVE: To investigate sex differences in the pharmacological treatment of hypertension in primary care.

DESIGN: Cross-sectional study among 14,384 patients with hypertension from the Julius General Practitioners' Network, without cardiovascular disease or diabetes, treated with antihypertensive medications.

METHODS: We compared men and women in the number and type of prescribed antihypertensives and their blood pressure.

RESULTS: Women (n=8596) and men (n=5788) were prescribed the same number of antihypertensive agents on average (1.8). Women received lower dosages, more often beta-blockers (35% vs. 26%, p<0.001) and diuretics (54% vs. 51%, p<0.001), but less often ACE inhibitors (35% vs. 46%, p<0.001) and calcium channel blockers (29% vs. 36%, p<0.001). Blood pressure control was more often achieved in women than in men (50% vs. 46%, p<0.001).

CONCLUSION: Although current guidelines do not distinguish between sexes, differences exist in the type and dosage of antihypertensives prescribed, and in the rate of blood pressure control.

Translated title of the contributionSex differences in the pharmacological treatment of hypertension in primary care
Original languageDutch
Article numberD8674
JournalNederlands Tijdschrift voor Geneeskunde
Volume169
Publication statusPublished - 11 Sept 2025

Keywords

  • Humans
  • Hypertension/drug therapy
  • Male
  • Antihypertensive Agents/therapeutic use
  • Female
  • Cross-Sectional Studies
  • Primary Health Care
  • Middle Aged
  • Sex Factors
  • Aged
  • Blood Pressure/drug effects
  • Practice Patterns, Physicians'
  • Calcium Channel Blockers/therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors/therapeutic use
  • Adrenergic beta-Antagonists/therapeutic use

Fingerprint

Dive into the research topics of 'Sex differences in the pharmacological treatment of hypertension in primary care'. Together they form a unique fingerprint.

Cite this